TDOC — Teladoc Health, Inc.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 1477449 ·
Last close
$6.71
Market Cap
$1.22B
52W High
$9.89
52W Low
$6.26
ADV30
5,492,306
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 613,845,000 | 416,319,000 | -48,729,000 | -63,837,000 | 2,807,261,000 | 750,738,000 | 1,470,945,000 |
| Dec 2025 | 642,269,000 | 445,221,000 | -26,968,000 | -25,143,000 | 2,858,300,000 | 781,084,000 | 1,472,594,000 |
| Sep 2025 | 626,439,000 | 439,260,000 | -35,456,000 | -49,507,000 | 2,878,547,000 | 726,249,000 | 1,486,432,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$261,184,000
Investing CF
$-161,151,000
Financing CF
$-4,062,000
CapEx
$-143,052,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-11.43
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-16,532,967,000
Inventory
$28,823,000
Receivables
$230,883,000
ST Investments
—
EBIT TTM
$-162,640,000
Pretax Income TTM
$-182,593,000
Interest Exp TTM
$19,953,000
Analysts
19
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,489,479,936
EBITDA
$64,563,000
Free Cash Flow
$191,039,504
Enterprise Value
$1,480,957,824
Total Cash
$774,348,032
Total Debt
$1,036,206,016
Shares Out
181,684,021
Trailing EPS
$-0.99
Book Value
$7.21
ROE
-13.0%
ROA
-3.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,529,977,000 | -163,397,000 | -200,322,000 | 2,858,300,000 | 1,472,594,000 | — | 294,357,000 |
| Dec 2024 | 2,569,574,000 | -208,788,000 | -1,001,245,000 | 3,516,524,000 | 2,025,445,000 | — | 293,680,000 |
| Dec 2023 | 2,602,415,000 | -210,501,000 | -220,368,000 | 4,392,369,000 | 2,066,296,000 | — | 350,021,000 |
| Dec 2022 | 2,406,840,000 | -227,366,000 | -13,659,531,000 | 4,345,355,000 | 2,037,610,000 | — | 189,292,000 |
TTM Snapshot
Revenues TTM
$1,912,148,000
NetIncome TTM
$-163,825,000
OpCashFlow TTM
$0
Assets (Latest)
$3,516,524,000
Forward EPS
$-0.61
Max Pain — expiry 2026-08-07
max pain strike: $6.50 · spot: $6.71 · call oi: 6,035 · put oi: 1,303
Expected Move to 2026-08-07:
±$0.38
(5.66%) —
implied range
$6.33 –
$7.09
· ATM straddle on $6.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OMDA | Omada Health, Inc. | $1.20B | $20.18 | — |
| USPH | U S PHYSICAL THERAPY INC /NV | $1.15B | $75.86 | — |
| PNTG | Pennant Group, Inc. | $1.34B | $38.61 | — |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.09B | $11.35 | — |
| PSNL | Personalis, Inc. | $1.44B | $13.52 | — |
News headlines (Yahoo Finance, 1h cache)
Are Investors Undervaluing Teladoc Health (TDOC) Right Now?
2026-08-03 13:40 · Yahoo
Teladoc Health (TDOC) Could Be 56% Undervalued As Weak Results Reset Expectations
2026-07-31 10:06 · Yahoo
Teladoc (TDOC) Stock Plummets on Disappointing Q2 Earnings Results
2026-07-30 20:26 · Yahoo
Teladoc Health Q2 Earnings Call Highlights
2026-07-30 12:03 · Yahoo
Teladoc lowers revenue outlook amid BetterHelp demand headwinds
2026-07-30 11:25 · Yahoo
Teladoc Health Q2 Loss Widens, Revenue Falls; 2026 Guidance Updated
2026-07-30 10:17 · Yahoo
Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
2026-07-29 23:30 · Yahoo
Teladoc (TDOC) Reports Q2 Loss, Lags Revenue Estimates
2026-07-29 22:25 · Yahoo
Seeking Clues to Teladoc (TDOC) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
2026-07-28 13:15 · Yahoo
Teladoc Health, Inc. Q2 2026 Earnings Call Summary
2026-07-30 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.